Low Price Warrantied inventory at competitive prices
Find it fast Search the world's largest inventory of electronic components by manufacturer, category or part number
Get it fast All inventory ready to ship from our sellers
Quality guaranteed We sell only warrantied and traceable parts

Our Service

Industry's fastest RFQ turnaround. Get the answers you need now.

E-mail us at: sales@internetofcomponents.com


NSN Part NDC00173-0377-31 with NSN 6505-01-231-9931 by Glaxo Wellcome Inc - Fill RFQ Form

Mfg Part Number: NDC00173-0377-31 Alternate P/N: NDC00173037731
Manufacturer: Glaxo Wellcome Inc NSN : 6505-01-231-9931
NIIN : 012319931 Item Name : ceftazidime for inj
CAGE Code : 34006

Thank you for your interest in our available NDC00173-0377-31 NSN part. This part number NDC00173-0377-31 is a Ceftazidime For Inj listed under the FSC , and it is manufactured by Glaxo Wellcome Inc. At Internet of Components, all of our stock and inventory are available for purchase today, ready to ship with short lead times and competitive pricing. Whether you are in need of parts that are new, used, or obsolete, our team of industry experts is readily available 24/7x365 to fulfill all of your operational

“*” Symbols for mandatory fields

PRODUCT DETAILS



Note : We Will Not Share Your Information To Any Third Parties.

CONTACT INFORMATION

   * By clicking this box, I acknowledge that I have read and accept the ASAP Semiconductor Terms and Conditions and agree that all quotes and purchase orders are exclusively subject to the ASAP Semiconductor Terms and Conditions.
  • I consent to receive email communications from ASAP Semiconductor and can unsubscribe at any time.
  • ASAP Semiconductor is a wholly independent aftermarket parts distributor.
  • This website is intended for quotations based on part numbers only. Please DO NOT submit drawings, technical data, or other specifications through this portal.

Internet of Components is a premier supplier of NDC00173-0377-31 NSN component, and we carry recently requested NSN components such as 6505012319931. We strive to only provide our customers with quality parts, which is why we choose to source our inventory from thousands of global manufacturers such as Glaxo Wellcome Inc. If you are interested in this particular item, we invite you to begin the purchasing process for NDC00173-0377-31 today by filling out and submitting an Instant RFQ. Once received, a member of our staff will review and reach out to you in 15 minutes or less to provide a personalized quote that caters towards your individual needs. Get started on the purchasing process today and see how we are revolutionizing the purchasing process.

Upload RFQ Sheet
If you have more than one item, upload your spreadsheet here

NSN Information for Part Number NDC00173-0377-31 with NSN 6505-01-231-9931, 6505012319931

NSNFSCNIINCLSHazmatDEMILCancelled NSN
6505-01-231-9931

Item Description:

Ceftazidime For Inj

6505012319931MP
CIICHCCESDPMICCriticalityENAC
U A
Part NumberISCRNVCRNCCHCCMSDSSADC
NDC00173-0377-31523

Characteristics Data of NSN 6505-01-231-9931, 6505012319931

MRCCriteriaCharacteristic
AGXWPHYSICAL FORMPOWDER
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH500.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
CBBLFEATURES PROVIDEDSTERILE
CQCTPRIMARY CONTAINER TYPEVIAL
CRLKPRIMARY CONTAINER CONTENT QUANTITY500.000 GRAMS
CSCWTOTAL PRIMARY CONTAINER QUANTITY25
CSGSADMINISTRATIONINTRAMUSCULAR OR INTRAVENOUS
CXCYIII PART NAME ASSIGNED BY CONTROLLING AGENCYCEFTAZIDIME FOR INJECTION USP 500GM VIAL 25S
MDESMEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
SUPPIII SUPPLEMENTARY FEATURESMEDSEP ITEM FOR DOD,GLAXO INC
THPEIII THERAPEUTIC EQUIVALENTANY A RATED DRUG

  Related NSN Parts to NDC00173-0377-31



Semiconductor's Certifications and Memberships
Thank You for Visiting Internet of Components.

Don’t forget That If You’d Ever Like a Quote for Parts Within 15 Minutes or Less, You Can Fill out the Instant RFQ form On this Website’S Homepage.

Request for Quote

We use cookies to ensure that we provide you with the most exceptional experience on our website. If you continue to use this site we will assume that you are happy with it.